This summer the first CBD oil drug was approved by the FDA to treat rare and severe forms of epilepsy in patients over the age of 2.
The drug, Epidiolex, was labeled as a Schedule V drug, legal for sale and use in the U.S by the U.S. Department of Drug Enforcement this September.
Epidiolex is approved for the treatment of two rare and severe forms of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome. Epidiolex contains hemp extract, derived from the cannabis plant, and has been shown to reduce epileptic seizures.
FDA Commissioner Scott Gottlieb, MD stated:
“The FDA is committed to advancing scientific research and drug development programs that properly evaluate the active ingredients contained in marijuana. Adequate and well-controlled clinical studies supported Epidiolex’s approval, so prescribers can have confidence in the drug’s uniform strength and consistent delivery that support appropriate dosing needed for treating patients with these complex and serious epilepsy syndromes. The FDA will continue to support rigorous scientific research on the potential medical uses of marijuana-derived products and stand ready to work with product developers who are interested in bringing patients safe and effective, high quality products.”
Image: GW Pharmaceuticals
The drug, developed by GW pharmaceuticals grows its own plants in order to extract high-quality CBD with powerful health benefits.
This is the first time that a hemp product has been approved by the FDA and paves the way for future research for other CBD/hemp-extract medicines and products.
The opioid crisis is a significant global health problem. Despite the current treatments available for opioid-dependent patients, the majority of patients relapse. A recent study out of Mount Sinai Hospital in New York found that CBD oil helped reduce cue-induced cravings and anxiety in a small sample of heroin dependent patients.
Trying to “find” work life balance is an invitation to fail. It simply can’t be done. Mastering the latest productivity or time management technique will not bring balance into your life - nor will the latest apps or gadgets.
The reason why we fail is our focus and mind set tends to be, “if I work long enough, I can get everything done.” But this is an illusion and there is always more to do. This month, we're focusing on our mental health - and that includes finding
This May, O2 Living and the JCK Foundation have partnered to raise awareness for mental health! We're featuring blogs and articles on mental health issues. This week we're talking about how you may be able to manage and deal with your stress from the inside out.